<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:50:31 -0700</creation_date>
  <update_date>2013-05-27 11:29:10 -0600</update_date>
  <accession>HMDBP00523</accession>
  <secondary_accessions>
    <accession>5771</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>1-alkyl-2-acetylglycerophosphocholine esterase</synonym>
    <synonym>2-acetyl-1-alkylglycerophosphocholine esterase</synonym>
    <synonym>Group-VIIA phospholipase A2</synonym>
    <synonym>LDL-PLA(2)</synonym>
    <synonym>LDL-associated phospholipase A2</synonym>
    <synonym>PAF 2-acylhydrolase</synonym>
    <synonym>PAF acetylhydrolase</synonym>
    <synonym>gVIIA-PLA2</synonym>
  </synonyms>
  <gene_name>PLA2G7</gene_name>
  <general_function>Involved in 1-alkyl-2-acetylglycerophosphocholine esterase activity</general_function>
  <specific_function>Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.
</specific_function>
  <pathways>
    <pathway>
      <name>Ether lipid metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00565</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00042</accession>
      <name>Acetic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11128</accession>
      <name>LysoPC(0:0/18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03752</accession>
      <name>LysoPC(10:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10379</accession>
      <name>LysoPC(14:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10380</accession>
      <name>LysoPC(14:1(9Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10381</accession>
      <name>LysoPC(15:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10382</accession>
      <name>LysoPC(16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10383</accession>
      <name>LysoPC(16:1(9Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12108</accession>
      <name>LysoPC(17:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10384</accession>
      <name>LysoPC(18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10385</accession>
      <name>LysoPC(18:1(11Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02815</accession>
      <name>LysoPC(18:1(9Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10386</accession>
      <name>LysoPC(18:2(9Z,12Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10387</accession>
      <name>LysoPC(18:3(6Z,9Z,12Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10388</accession>
      <name>LysoPC(18:3(9Z,12Z,15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10389</accession>
      <name>LysoPC(18:4(6Z,9Z,12Z,15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10390</accession>
      <name>LysoPC(20:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10391</accession>
      <name>LysoPC(20:1(11Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10392</accession>
      <name>LysoPC(20:2(11Z,14Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10393</accession>
      <name>LysoPC(20:3(5Z,8Z,11Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10394</accession>
      <name>LysoPC(20:3(8Z,11Z,14Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10395</accession>
      <name>LysoPC(20:4(5Z,8Z,11Z,14Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10396</accession>
      <name>LysoPC(20:4(8Z,11Z,14Z,17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10397</accession>
      <name>LysoPC(20:5(5Z,8Z,11Z,14Z,17Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10398</accession>
      <name>LysoPC(22:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10399</accession>
      <name>LysoPC(22:1(13Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10400</accession>
      <name>LysoPC(22:2(13Z,16Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10401</accession>
      <name>LysoPC(22:4(7Z,10Z,13Z,16Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10402</accession>
      <name>LysoPC(22:5(4Z,7Z,10Z,13Z,16Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10403</accession>
      <name>LysoPC(22:5(7Z,10Z,13Z,16Z,19Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10404</accession>
      <name>LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10405</accession>
      <name>LysoPC(24:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10406</accession>
      <name>LysoPC(24:1(15Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11149</accession>
      <name>LysoPC(O-18:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10407</accession>
      <name>LysoPC(P-16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB10408</accession>
      <name>LysoPC(P-18:1(9Z))</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02111</accession>
      <name>Water</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, acting on ester bonds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>carboxylesterase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>1-alkyl-2-acetylglycerophosphocholine esterase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>primary metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>lipid metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>lipid catabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>low-density lipoprotein particle</description>
      <go_id>GO:0034362</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>1-alkyl-2-acetylglycerophosphocholine esterase activity</description>
      <go_id>GO:0003847</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>calcium-independent phospholipase A2 activity</description>
      <go_id>GO:0047499</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>phospholipid binding</description>
      <go_id>GO:0005543</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>lipid catabolic process</description>
      <go_id>GO:0016042</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>lipid oxidation</description>
      <go_id>GO:0034440</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>low-density lipoprotein particle remodeling</description>
      <go_id>GO:0034374</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>plasma lipoprotein particle oxidation</description>
      <go_id>GO:0034441</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>positive regulation of inflammatory response</description>
      <go_id>GO:0050729</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>positive regulation of monocyte chemotaxis</description>
      <go_id>GO:0090026</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Secreted</subcellular_location>
    <subcellular_location>extracellular space</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>6</chromosome_location>
    <locus>6p21.2-p12</locus>
    <gene_sequence>&gt;1326 bp
ATGGTGCCACCCAAATTGCATGTGCTTTTCTGCCTCTGCGGCTGCCTGGCTGTGGTTTAT
CCTTTTGACTGGCAATACATAAATCCTGTTGCCCATATGAAATCATCAGCATGGGTCAAC
AAAATACAAGTACTGATGGCTGCTGCAAGCTTTGGCCAAACTAAAATCCCCCGGGGAAAT
GGGCCTTATTCCGTTGGTTGTACAGACTTAATGTTTGATCACACTAATAAGGGCACCTTC
TTGCGTTTATATTATCCATCCCAAGATAATGATCGCCTTGACACCCTTTGGATCCCAAAT
AAAGAATATTTTTGGGGTCTTAGCAAATTTCTTGGAACACACTGGCTTATGGGCAACATT
TTGAGGTTACTCTTTGGTTCAATGACAACTCCTGCAAACTGGAATTCCCCTCTGAGGCCT
GGTGAAAAATATCCACTTGTTGTTTTTTCTCATGGTCTTGGGGCATTCAGGACACTTTAT
TCTGCTATTGGCATTGACCTGGCATCTCATGGGTTTATAGTTGCTGCTGTAGAACACAGA
GATAGATCTGCATCTGCAACTTACTATTTCAAGGACCAATCTGCTGCAGAAATAGGGGAC
AAGTCTTGGCTCTACCTTAGAACCCTGAAACAAGAGGAGGAGACACATATACGAAATGAG
CAGGTACGGCAAAGAGCAAAAGAATGTTCCCAAGCTCTCAGTCTGATTCTTGACATTGAT
CATGGAAAGCCAGTGAAGAATGCATTAGATTTAAAGTTTGATATGGAACAACTGAAGGAC
TCTATTGATAGGGAAAAAATAGCAGTAATTGGACATTCTTTTGGTGGAGCAACGGTTATT
CAGACTCTTAGTGAAGATCAGAGATTCAGATGTGGTATTGCCCTGGATGCATGGATGTTT
CCACTGGGTGATGAAGTATATTCCAGAATTCCTCAGCCCCTCTTTTTTATCAACTCTGAA
TATTTCCAATATCCTGCTAATATCATAAAAATGAAAAAATGCTACTCACCTGATAAAGAA
AGAAAGATGATTACAATCAGGGGTTCAGTCCACCAGAATTTTGCTGACTTCACTTTTGCA
ACTGGCAAAATAATTGGACACATGCTCAAATTAAAGGGAGACATAGATTCAAATGTAGCT
ATTGATCTTAGCAACAAAGCTTCATTAGCATTCTTACAAAAGCATTTAGGACTTCATAAA
GATTTTGATCAGTGGGACTGCTTGATTGAAGGAGATGATGAGAATCTTATTCCAGGGACC
AACATTAACACAACCAATCAACACATCATGTTACAGAACTCTTCAGGAATAGAGAAATAC
AATTAG</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>441</residue_number>
    <molecular_weight>50076.99</molecular_weight>
    <theoretical_pi>7.556</theoretical_pi>
    <pfams>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Platelet-activating factor acetylhydrolase
MVPPKLHVLFCLCGCLAVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGN
GPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNI
LRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHR
DRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDID
HGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMF
PLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFA
TGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGT
NINTTNQHIMLQNSSGIEKYN</protein_sequence>
  </protein_properties>
  <genbank_protein_id/>
  <uniprot_id>Q13093</uniprot_id>
  <uniprot_name>PAFA_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>3D59</pdb_id>
    <pdb_id>3D5E</pdb_id>
    <pdb_id>3F96</pdb_id>
    <pdb_id>3F97</pdb_id>
    <pdb_id>3F98</pdb_id>
    <pdb_id>3F9C</pdb_id>
  </pdb_ids>
  <genbank_gene_id>U20157</genbank_gene_id>
  <genecard_id>PLA2G7</genecard_id>
  <geneatlas_id>PLA2G7</geneatlas_id>
  <hgnc_id>HGNC:9040</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Le Trong H, Cousens LS, Zimmerman GA, et al.: Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 1995 Apr 6;374(6522):549-53.</reference_text>
      <pubmed_id>7700381</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tew DG, Southan C, Rice SQ, Lawrence MP, Li H, Boyd HF, Moores K, Gloger IS, Macphee CH: Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):591-9.</reference_text>
      <pubmed_id>8624782</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6.  Nature. 2003 Oct 23;425(6960):805-11.</reference_text>
      <pubmed_id>14574404</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tjoelker LW, Eberhardt C, Unger J, Trong HL, Zimmerman GA, McIntyre TM, Stafforini DM, Prescott SM, Gray PW: Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem. 1995 Oct 27;270(43):25481-7.</reference_text>
      <pubmed_id>7592717</pubmed_id>
    </reference>
    <reference>
      <reference_text>Samanta U, Bahnson BJ: Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis. J Biol Chem. 2008 Nov 14;283(46):31617-24. Epub 2008 Sep 10.</reference_text>
      <pubmed_id>18784071</pubmed_id>
    </reference>
    <reference>
      <reference_text>Samanta U, Kirby SD, Srinivasan P, Cerasoli DM, Bahnson BJ: Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes. Biochem Pharmacol. 2009 Aug 15;78(4):420-9. Epub 2009 Apr 24.</reference_text>
      <pubmed_id>19394314</pubmed_id>
    </reference>
    <reference>
      <reference_text>Stafforini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, Imaizumi T, Takamatsu S, Zimmerman GA, McIntyre TM, Gray PW, Prescott SM: Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest. 1996 Jun 15;97(12):2784-91.</reference_text>
      <pubmed_id>8675689</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yamada Y, Yokota M: Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281--&amp;gt;Arg mutation. Biochem Biophys Res Commun. 1997 Jul 30;236(3):772-5.</reference_text>
      <pubmed_id>9245731</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hiramoto M, Yoshida H, Imaizumi T, Yoshimizu N, Satoh K: A mutation in plasma platelet-activating factor acetylhydrolase (Val279--&amp;gt;Phe) is a genetic risk factor for stroke. Stroke. 1997 Dec;28(12):2417-20.</reference_text>
      <pubmed_id>9412624</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yamada Y, Ichihara S, Fujimura T, Yokota M: Identification of the G994--&amp;gt; T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Metabolism. 1998 Feb;47(2):177-81.</reference_text>
      <pubmed_id>9472966</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yoshida H, Imaizumi T, Fujimoto K, Itaya H, Hiramoto M, Yoshimizu N, Fukushi K, Satoh K: A mutation in plasma platelet-activating factor acetylhydrolase (Val279Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension. Thromb Haemost. 1998 Sep;80(3):372-5.</reference_text>
      <pubmed_id>9759612</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kruse S, Mao XQ, Heinzmann A, Blattmann S, Roberts MH, Braun S, Gao PS, Forster J, Kuehr J, Hopkin JM, Shirakawa T, Deichmann KA: The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Am J Hum Genet. 2000 May;66(5):1522-30. Epub 2000 Mar 24.</reference_text>
      <pubmed_id>10733466</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
  </metabolite_references>
</protein>
